WW International Inc. (WW)
NASDAQ (NGS) NASDAQ (NGS) Primary 
WW International (WW) Shows Fast-paced Momentum But Is Still a Bargain Stock
WW International (WW) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
WW International Stock Surges 67% in 3 Months: Is it Too Late to Buy?
WW's proven behavioral programs enhance its value proposition for customers seeking comprehensive weight management solutions.
More turnover at the top, but this bull still believes in the Weight Watchers parent
D.A. Davidson reckons WW is a buy as its customers need more than a prescription.
Here's Why WW International (WW) is Poised for a Turnaround After Losing -26.67% in 4 Weeks
The heavy selling pressure might have exhausted for WW International (WW) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
WW International, Inc. (WW) Q3 2024 Earnings Call Transcript
WW International, Inc. (NASDAQ:WW ) Q3 2024 Results Conference Call November 6, 2024 8:30 AM ET Company Participants David Helderman - Vice President, Investor Relations Tara Comonte - Interim President & Chief Executive Officer Heather Stark - Chief Financial Officer Donna Boyer - Chief Product Officer Conference Call Participants Nathan Feather - Morgan Stanley Alex Fuhrman - Craig-Hallum Capital Group Karru Martinson - Jefferies Henry Carr - UBS Operator Good day, and welcome to the WW International Third Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode.
WW International (WW) Beats Q3 Earnings and Revenue Estimates
WW International (WW) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago.
WW Stock Rises as WeightWatchers Expands Drug Offerings
Shares of WW International Inc (WW, Financial) soared by 43.09% today due to the company's strategic move to expand its clinical weight management services. This expansion includes the introduction of compounded semaglutide, which offers a cost-effective and accessible alternative to popular medications like Ozempic and Wegovy, particularly during the current supply shortages.
WW International (WW) Surges After Adding Semaglutide to Weight Loss Program
WW International (WW, Financial) experienced a significant stock price increase, soaring 20.7% to $1.40. Early trading saw the stock rise as much as 46.5%.
WW International (WW) Surges After Introducing Compounded Semaglutide to Weight Loss Plans
WW International (WW, Financial), a provider of weight loss solutions, experienced a significant stock movement with an initial surge of over 46.5%, which later narrowed to around a 25% increase, reaching $1.45. This follows a nearly 47% rise in the previous trading session.
WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering
Shares of WW International (WW), better known as WeightWatchers, jumped nearly 25% Tuesday when the dieting services company announced it is offering a copycat version of blockbuster weight-loss drugs.
WeightWatchers adds compounded version of Novo's obesity drug to weight-loss program
WeightWatchers said on Tuesday it is adding a compounded version of Novo Nordisk's obesity drug Wegovy to its weight-management programs.
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte has stepped in to serve as interim CEO.
